Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis

Mycoses

Volumn 40, Issue 7-8, 1997, Pages 279-282

  Dannaoui, E ^a   Lacoste, V ^a   Prat, C ^a   Piens, M A ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Candida; Candidosis; Fluconazole; Oropharynx; Susceptibility testing

Indexed keywords

FLUCONAZOLE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; FUNGUS IDENTIFICATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; OROPHARYNX; PRIORITY JOURNAL;

EID: 0031468396     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1997.tb00232.x     Document Type: Article

References (17)

1. Fox, R., Neal, K. R., Leen, C. L. S., Ellis, M. E. & Mandal, B. K. (1991) Fluconazole resistant Candida in AIDS. J. Infect. 22, 201-204.
2. Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E. & Trautmann, M. (1994) Emergence of fluconazole-resistant strains of Candida albicana in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32, 2092-2098.
3. Akova, M., Akalin, H. E., Uzun, Ö. & Gur, D. (1991) Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 10, 598-599.
4. Pfaller, M. & Wenzel, R. (1992) Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11, 287-291.
5. Millon, L., Reboux, G. & Barale, T. (1994) Emergence de Candida glabrata et Candida krusei chez des patients séropositifs pour le VIH atteints de candidose oropharyngée, traités de façon prolongée par le fluconazole. J. Mycol. Med. 4, 90-92.
6. National Committee for Clinical Laboratory Standards. (1992) Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. NCCLS, Villanova, PA.
7. Pfizer. (1992) Antifungal susceptibility testing. A manual of methods in development. Pfizer inc., New York.
8. Galgiani, J. N. (1990) Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Rev. Infect. Dis. 12 (Suppl. 3), 272-275.
9. Ohkawa, M., Tokunaga, S., Takashima, M., Nishikawa, T., Hisazumi, H., Fujita, S. & Wheat, R. W. (1990) In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents. Chemotherapy 36, 396-402.
10. Ghannoum, M. A., Rex, J. H. & Galgiani, N. (1996) Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J. Clin. Microbiol. 34, 489-495.
11. Troke, P. F., Andrews, R. J., Pye, G. W. & Richardson, K. (1990) Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Rev. Inject. Dis. 12 (Suppl. 3), 276-280.
12. Goa, K. L. & Barradell, L. B. (1995) Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs 50, 658-690.
13. Dellion, S., Improvisi, L., Dupont, B. & Dromer, F. (1995) Diversity among yeasts isolated from patients with AIDS and oral candidosis: focus on fluconazole susceptibility testing results. J. Mycol. Med. 5, 98-101.
14. Pfaller, M. A., Rhine-Chalberg, J. & Redding, W. (1994) Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32, 59-64.
15. Baily, G. G., Perry, F. M., Denning, D. W. & Mandal, B. K. (1994) Fluconazole-resistant candidosis in an HIV cohort. AIDS 8, 787-792.
16. Odds, F. G. & Bernaerts, R. (1994) CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32, 1923-1929.
17. Pfaller, M. A., Houston, A. & Coffmann, S. (1996) Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34, 58-61.